Niki BioSolutions NIKI
NASDAQ NIKI
$4.81 -0.09 (-1.83%)
As of: Oct 1, 2026 · 2:11 PM EDT

Niki BioSolutions (NIKI) Capital Leases (2018 - 2022)

Updated

Niki BioSolutions' Capital Leases was -$49,358 in Q4 2022, compared with -$53,846 a year earlier.

Analysis

Niki BioSolutions (NIKI) Capital Leases (2018 - 2022) Analysis & Trends

From Q4 2018 onward, Niki BioSolutions has reported Capital Leases for 9 quarters.

  • In earlier years, Capital Leases was -$53,846 in FY2021, -$53,845 in FY2020, $97,319 in FY2019 (-32.4%) and $143,873 in FY2018.
  • Quarterly Capital Leases has moved between -$58,332 (Q4 2018) and $120,941 (Q2 2019) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Niki BioSolutions 2.67 Mn 2.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -49,358.00
Jun 30, 2022 -26,922.00
Dec 31, 2021 -53,846.00
Jun 30, 2021 -26,922.00
Dec 31, 2020 -53,845.00
Jun 30, 2020 72,986.00
Dec 31, 2019 -53,843.00
Jun 30, 2019 120,941.00
Dec 31, 2018 -58,332.00
API Access

Niki BioSolutions Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=NIKI&period=max&api_key=YOUR_API_KEY